Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study in patients with stage 4 and 5 chronic kidney disease is to determine whether rosiglitazone can reduce inflammatory markers and to investigate its effect on intima media thickness, calcification and pulse wave velocity.
Epistemonikos ID: e870a2425e4b5b0af55464f746f0f15b76101353
First added on: May 04, 2024